Monitoring monocyte HLA-DR expression and CD4 + T lymphocyte count in dexamethasone-treated severe COVID-19 patients

Abstract Background A 10-day dexamethasone regimen has emerged as the internationally adopted standard-of-care for severe COVID-19 patients. However, the immune response triggered by SARS-CoV-2 infection remains a complex and dynamic phenomenon, leading to various immune profiles and trajectories. T...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Guillaume Monneret, Nicolas Voirin, Jean-Christophe Richard, Martin Cour, Thomas Rimmelé, Lorna Garnier, Hodane Yonis, Remy Coudereau, Morgane Gossez, Christophe Malcus, Florent Wallet, Marie-Charlotte Delignette, Frederic Dailler, Marielle Buisson, Laurent Argaud, Anne-Claire Lukaszewicz, Fabienne Venet, for the RICO study group
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-05-01
Edice:	Annals of Intensive Care
Témata:	Immunomonitoring Monocyte HLA-DR CD4 COVID-19 Dexamethasone
On-line přístup:	https://doi.org/10.1186/s13613-024-01310-5
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!